Abstract
The ethical basis of medical experimentation on human subjects is an issue at the core of bioethics. In such experimentation the balance between individual and collective rights, and in particular the balance between physicians’ therapeutic obligation to their patients — the individual ethic (Clayton 1982), and their duty to further scientific knowledge for the collective good — the collective ethic (Lellouch and Schwartz 1971), has become an issue of major importance. Much of the debate about this issue has now been focused on the ethical status and role of the clinical trial in modern scientific medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armitage, P. 1982 The Role of Randomisation in Clinical Trials Statistics. Medicine 1: 345–352.
ARMS 1989 Handbook of arms Therapy Centres. Stansted, UK: Action for Research into Multiple Sclerosis.
Arpillange, P. and Dion, S. 1986 The Ethical Approach to Randomisation in Oncology Drugs. Experimental Clinical Research 12: 99–103.
Barber, B. 1981 Biomedical Research as a Social Process. In Wechsler, H., Lamont-Havers, R.W. and Cahill, G.F. (eds.) The Social Context of Medical Research. Cambridge, Mass.: Ballinger. Pp. 127–142.
Barnes, J.A. 1979 Who Should Know What? Social Science, Privacy and Ethics. Harmondsworth: Penguin.
Barnes, M.P. et al. 1985 Hyperbaric Oxygen and Multiple Sclerosis: Short Term Results of a Placebo-Controlled Double Blind Trial. Lancet 1: 297–300.
Barnes, M.P. et al. 1987 Hyperbaric Oxygen and Multiple Sclerosis: Final Results of a Placebo-Controlled, Double Blind Trial. Journal of Neurology, Neurosurgery and Psychiatary 50: 1402–1406.
Bates, D. 1986 Hyperbaric Oxygen Therapy in Multiple Sclerosis. Journal of the Royal Society of Medicine 79: 535–537.
Baum, M. 1982 The Ethics of Clinical Trials and Informed Consent. Experientia (supplement). 41: 300–308.
Baum, M. 1983 Commentary. Journal of Medical Ethics 9: 92–93.
Baum, M. 1986 Do We Need Informed Consent? Lancet 2: 911–912.
Behnke, A.R. 1977 A Brief History of Hyperbaric Medicine. In Davis, J.C. and Hunt, T.K. (eds.) Hyperbaric Oxygen Therapy. Bethesda: Undersea Medical Society. Pp. 3–10.
Berlant, J.L. 1975 Profession and Monopoly. Berkeley: University of California Press.
Boschetty, V. and Cernoch, J. 1970 Aplikace Kysliku za Pretlaku Nekterych Neurologickych Anemocneni. Bratislav Lek Lesty 53: 298–302.
Burkhardt, R. and Kienle, G. 1983 The Practical and Ethical Defects of Surgical Randomised Prospective Trials. Journal of Medical Ethics 9: 90–92.
Chalmers, T.C. 1982 Randomised Clinical Trials and the Consumers. In Tygstrup, N., Lachin, J.M. and Juhl, E. (eds.) The Randomised Clinical Trial and Therapeutic Decisions. New York: Marcel Dekker. Pp. 257–263.
Clayton, D. 1982 Ethically Optimised Designs. British Journal of Clinical Pharmacology 13: 469–480.
Cochrane, A.L. 1972 Effectiveness and Efficiency: Random Reflections on Health Services. London: Nuffield Provincial Hospitals Trust.
Confavreux, C. et al. 1986 Hyperbaric Oxygen Therapy in Multiple Sclerosis: A Double-Blind Randomised Placebo-Controlled Study. Presse Médicale 15: 1319–1322.
Davidson, D.L.W. 1983 Hyperbaric Oxygen Therapy in the Treatment of Multiple Sclerosis. Stansted, UK: Action for Research into Multiple Sclerosis Education Service.
Ditchley Foundation Report 1980 The Scientific and Ethical Basis of the Clinical Evaluation of Medicines. European Journal of Clinical Pharmacology 18: 129–134.
Fischer, B.H., Marks, M. and Reich, T. 1983 Hyperbaric Oxygen Treatment of Multiple Sclerosis. The New England Journal of Medicine 308: 181–186.
Freidson, E. 1970 Profession of Medicine: A Study of the Sociology of Applied Knowledge. New York: Dodds Mead.
Friedman, L.M., Furberg, CD. and De Mets, D.L. 1980 Fundamentals of Clinical Trials. Boston: John Wright.
Gifford, F. 1986 The Conflict Between Randomised Clinical Trials and the Therapeutic Obligation. Journal of Medicine and Philosophy 11: 347–366.
Gilmour, D. 1977 Psychological Factors in Clinical Trials. In Johnson, F.N. and Johnson, S. (eds.) Clinical Trials. Oxford: Blackwell. Pp. 147–161.
Greer, S. 1984 The Psychological Dimension in Cancer Treatment. Social Science and Medicine 18: 345–349.
Gritzer, B. and Arluke, A. 1985 The Making of Rehabilitation. Berkeley: University of California Press.
Hansen, E.H. and Launso, L. 1987a Clinical Trials: Towards a Different Model. Journal de pharmacie clinique 6: 67–74.
Hansen, E.H. and Launso, L. 1987b Development, Use and Evaluation of Drugs: The Dominating Technology in the Health Care System. Social Science and Medicine 25: 65–73.
Hansen, E.H. and Launso, L. 1988 Is the Controlled Clinical Trial Sufficient as a Drug Technology Assessment? Working Paper, Royal Danish School of Pharmacy, Copenhagen.
Harpur, G.D. 1986 Hyperbaric Oxygen Therapy in Chronic Stable Multiple Sclerosis: Doubleblind Study. Neurology 36: 988–991.
Hasskarl, H.W. 1981 Legal Problems of Controlled Clinical Trials. Controlled Clinical Trials 1: 401–409.
Hunt, S., McEwan, J. and McKenna, S.P. 1986 Measuring Health Status. London: Croom Helm.
Ingelfinger, F.J. 1982 Randomised Controlled Trials and the Public. In Tygstrup, N., Lachin, J.M. and Juhl, E. (eds.) The Randomised Clinical Trial and Therapeutic Decisions. New York: Marcel Dekker. Pp. 277–281.
International Federation of Multiple Sclerosis Societies 1982 Therapeutic Claims in Multiple Sclerosis. New York: International Federation of Multiple Sclerosis Societies.
Jacobson, J.H., Morsch, J.H.C. and Rendall-Baker, L. 1965 The Historical Perspective on Hyperbaric Oxygen. Annals of the New York Academy of Sciences 117: 651–670.
James, P.B. 1982 Evidence for Sub-acute Fat Embolism as a Cause of Multiple Sclerosis. Lancet 1: 380–386.
Johnson, F.N. and Johnson, S. (eds.) 1977 Clinical Trials. Oxford: Blackwell.
Journal of Medical Ethics (Editorial) 1982 Research, Consent, Distress and Truth. Journal of Medical Ethics 8: 59–60.
Kadane, J.B. 1986 Progress Towards a More Ethical Method for Clinical Trials. Journal of Medicine and Philosophy 11: 385–404.
Kennedy, T.J. and Bennett, I.L. 1981 The Planning of Research: The Role of the Federal Government. In Wechsler, H., Lamont-Havers, R.W. and Cahill, G.F. (eds.) The Social Context of Medical Research. Cambridge, Mass.: Ballinger. Pp. 27–72
Kirby, M.D. 1983 Informed Consent: What Does it Mean? Journal of Medical Ethics 9: 69–75.
Kopelman, L. 1986 Consent and Randomised Clinical Trials: Are there Moral or Design Problems? Journal of Medicine and Philosophy 11: 317–346.
Lancet (Editorial) 1984 Consent: How Informed? Lancet 1: 1445–1447.
Lellouch, J. and Schwartz, D. 1971 L’essai thérapeutique: éthique individuelle ou éthique collective? Revue de l’Institut International de Statistique 39: 127–136.
Levine, R.J. 1987 The Apparent Incompatibility Between Informed Consent and Placebo-Controlled Clinical Trials. Clinical Pharmacology and Therapeutics 42: 247–256.
Lhermitte, F. et al. 1986 Double Blind Treatment of Chronic Multiple Sclerosis Using Hyperbaric Oxygen. Revue Neurologique 142: 201–206.
Macara, A.W. 1986 Informed Consent. Lancet 2: 1101.
McEwen, J., Martini, C.J.M. and Wilkins, N. 1983 Participation in Health. London: Croom Helm.
Marquis, D. 1986 An Argument That All Prerandomised Clinical Trials are Unethical. Journal of Medicine and Philosophy 11: 367–383.
Matthews, W.B. et al. 1985 McAlpine’s Multiple Sclerosis. Edinburgh: Churchill Livingstone.
Medical Research Council. 1948 Streptomycin Treatment of Pulmonary Tuberculosis. British Medical Journal 2: 769–782.
Meir, P. 1979 Terminating a Trial: The Ethical Problem. Clinical Pharmacology and Therapeutics 25: 633–640.
Moser, M. 1986 Randomised Clinical Trials: Problems and Values. American Journal of Emergency Medicine 4: 173–178.
Neubauer, R.A., Schnell, R. and Goldberg, G.S. 1979 Treatment of Multiple Sclerosis with Monoplace Hyperbaric Oxygenation. Paper presented to the 4th Conference on the Clinical Application of Hyperbaric Oxygen, Long Beach.
Neubauer, R.A. 1980 Exposure of Multiple Sclerosis Patients to Hyperbaric Oxygen at 1.5–2 A.T.A. Journal of the Florida Medical Association 67: 498–504.
Neubauer, R.A. 1983 Hyperbaric Oxygen Therapy of Multiple Sclerosis. Fort Lauderdale: Ocean Medical Center.
Nicholson, M. and McLaughlin, C. 1988 Social Constructionism and Medical Sociology: A Study of the Vascular Theory of Multiple Sclerosis. Sociology of Health and Illness 10: 234–261.
Prout, T.E. 1981 The Ethics of Informed Consent. Controlled Clinical Trials 1: 429–434.
Robinson, D. and Henry, S. 1977 Self-Help and Health. London: Martin Robertson
Robinson, I. 1987 Analysing the Structure of 23 Clinical Trials in Multiple Sclerosis. Neuroepidemiology 6: 46–76.
Robinson, I. 1988 Multiple Sclerosis. London: Tavistock.
Schaffner, K.F. 1986 Ethical Problems in Clinical Trials. Journal of Medicine and Philosophy 11: 297–316.
Silberberg, D.H. 1984 Problems in Evaluating New Treatments for Multiple Sclerosis. Annals of the New York Academy of Sciences 436: 418–422.
Simnett, J.D. 1982 We Need to Take a Fresh Look at Medical Research. Journal of Medical Ethics 8: 73–77.
Spodick, D.H. 1982 The Randomised Controlled Clinical Trial: Scientific and Ethical Bases. American Journal of Medicine 73: 420–425.
Teeling-Smith, G. (ed.) 1987 Measuring Health Status. London: Wiley.
Van Eys, J. 1982 Clinical Research and Clinical Care: Ethical Problems in the “War on Cancer.” American Journal of Pediatric Hematology and Oncology 4: 419–423.
Vere, D.W. 1983 Problems in Controlled Trials: A Critical Response. Journal of Medical Ethics 9: 85–89.
Von Eickstedt, K.W. 1983 The Ethical Position of the Attending Physician in Phase 3 of Clinical Investigations. International Journal of Pharmacology, Therapeutics and Toxicology 21: 529–533.
Waldenstrom, J. 1983 The Ethics of Randomisation. Progress in Clinical and Biological Research 128: 243–249.
Webster, C. et al. 1988 Longterm Hyperbaric Oxygen Therapy for Multiple Sclerosis. Stansted, UK: Action for Research into Multiple Sclerosis.
Wiles, C.M. et al. 1986 Hyperbaric Oxygen in Multiple Sclerosis: A Double Blind Trial. British Medical Journal 292: 367–371.
Worthington, J.A. et al. 1987 A Double Blind Crossover Trial Investigating the Efficacy of Hyperbaric Oxygen in Patients with Multiple Sclerosis. In Clifford, Rose F. and Jones, R. (eds.) Multiple Sclerosis: Immunological, Diagnostic and Therapeutic Aspects. London: J. Libbey.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Robinson, I. (1990). Clinical Trials and the Collective Ethic: The Case of Hyperbaric Oxygen Therapy and the Treatment of Multiple Sclerosis. In: Weisz, G. (eds) Social Science Perspectives on Medical Ethics. Culture, Illness, and Healing, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1930-3_2
Download citation
DOI: https://doi.org/10.1007/978-94-009-1930-3_2
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7361-5
Online ISBN: 978-94-009-1930-3
eBook Packages: Springer Book Archive